Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_assertion type Assertion NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_head.
- NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_assertion description "[Also, we found that secreted factors overexpressed by anti-VEGF treatment-resistant pancreatic cancer cells acted in an autocrine manner to induce epithelial-to-mesenchymal transition (EMT) and were thus responsible for increased aggressiveness of bevacizumab-resistant pancreatic tumors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_provenance.
- NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_assertion evidence source_evidence_literature NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_provenance.
- NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_assertion SIO_000772 21737511 NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_provenance.
- NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_assertion wasDerivedFrom befree-2016 NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_provenance.
- NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_assertion wasGeneratedBy ECO_0000203 NP907804.RATIjE0ncLJiPc1ixk0ruyPwiSO-IuF4OnFWftOaU8Sdg130_provenance.